Okay.
Let me go on to my second issue of concern. As you know, there have been significant studies noting increases in costs related to the cost of medicines and other products with raising IP standards. One such study has indicated that CETA would increase prescription drug costs by approximately $2.8 billion. What precisely do you expect will happen to the price of medicines in Canada by harmonizing our IP laws with those of Europe in this agreement, in CETA?